Rank | Gene Set | Z-score |
---|---|---|
1 | establishment of integrated proviral latency (GO:0075713) | 5.18206400 |
2 | L-serine metabolic process (GO:0006563) | 4.61424383 |
3 | purine nucleobase biosynthetic process (GO:0009113) | 4.27269178 |
4 | folic acid-containing compound biosynthetic process (GO:0009396) | 4.24708607 |
5 | nucleobase biosynthetic process (GO:0046112) | 4.21423381 |
6 | establishment of viral latency (GO:0019043) | 4.15551398 |
7 | formation of translation preinitiation complex (GO:0001731) | 3.98141297 |
8 | IMP biosynthetic process (GO:0006188) | 3.91036725 |
9 | proteasome assembly (GO:0043248) | 3.87180657 |
10 | DNA replication checkpoint (GO:0000076) | 3.79991322 |
11 | protein maturation by protein folding (GO:0022417) | 3.75992376 |
12 | DNA strand elongation involved in DNA replication (GO:0006271) | 3.74784285 |
13 | mitotic nuclear envelope disassembly (GO:0007077) | 3.68252752 |
14 | DNA replication initiation (GO:0006270) | 3.65926227 |
15 | negative regulation of ubiquitin-protein transferase activity (GO:0051444) | 3.60766565 |
16 | negative regulation of ligase activity (GO:0051352) | 3.60766565 |
17 | DNA strand elongation (GO:0022616) | 3.53885805 |
18 | folic acid metabolic process (GO:0046655) | 3.43195323 |
19 | regulation of mitochondrial translation (GO:0070129) | 3.40720520 |
20 | protein localization to kinetochore (GO:0034501) | 3.40028796 |
21 | IMP metabolic process (GO:0046040) | 3.39545432 |
22 | protein complex localization (GO:0031503) | 3.37664985 |
23 | cullin deneddylation (GO:0010388) | 3.36923971 |
24 | telomere maintenance via semi-conservative replication (GO:0032201) | 3.36617356 |
25 | nuclear envelope disassembly (GO:0051081) | 3.35414722 |
26 | membrane disassembly (GO:0030397) | 3.35414722 |
27 | regulation of attachment of spindle microtubules to kinetochore (GO:0051988) | 3.31389042 |
28 | mitotic metaphase plate congression (GO:0007080) | 3.28087534 |
29 | regulation of gene silencing by RNA (GO:0060966) | 3.27708658 |
30 | regulation of posttranscriptional gene silencing (GO:0060147) | 3.27708658 |
31 | regulation of gene silencing by miRNA (GO:0060964) | 3.27708658 |
32 | cellular protein complex localization (GO:0034629) | 3.26230069 |
33 | nuclear pore organization (GO:0006999) | 3.22671075 |
34 | COPI coating of Golgi vesicle (GO:0048205) | 3.17321690 |
35 | Golgi transport vesicle coating (GO:0048200) | 3.17321690 |
36 | DNA unwinding involved in DNA replication (GO:0006268) | 3.14793810 |
37 | non-recombinational repair (GO:0000726) | 3.13816385 |
38 | double-strand break repair via nonhomologous end joining (GO:0006303) | 3.13816385 |
39 | DNA replication-dependent nucleosome organization (GO:0034723) | 3.09643988 |
40 | DNA replication-dependent nucleosome assembly (GO:0006335) | 3.09643988 |
41 | tRNA aminoacylation (GO:0043039) | 3.08030569 |
42 | amino acid activation (GO:0043038) | 3.08030569 |
43 | regulation of cellular amino acid metabolic process (GO:0006521) | 3.06618051 |
44 | telomere maintenance via recombination (GO:0000722) | 3.06373033 |
45 | NADPH regeneration (GO:0006740) | 3.05958113 |
46 | protein deneddylation (GO:0000338) | 3.05694918 |
47 | mitotic chromosome condensation (GO:0007076) | 3.04171528 |
48 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 3.03336547 |
49 | B cell mediated immunity (GO:0019724) | 3.02533716 |
50 | nucleobase-containing small molecule interconversion (GO:0015949) | 3.00098753 |
51 | protein K6-linked ubiquitination (GO:0085020) | 2.98991971 |
52 | regulation of ubiquitin-protein transferase activity (GO:0051438) | 2.98892059 |
53 | CENP-A containing nucleosome assembly (GO:0034080) | 2.98604479 |
54 | chromatin remodeling at centromere (GO:0031055) | 2.97385486 |
55 | immunoglobulin mediated immune response (GO:0016064) | 2.95752437 |
56 | ribosome biogenesis (GO:0042254) | 2.95691753 |
57 | positive regulation of ubiquitin-protein transferase activity (GO:0051443) | 2.95449102 |
58 | tetrahydrofolate metabolic process (GO:0046653) | 2.93529492 |
59 | regulation of transcription involved in G1/S transition of mitotic cell cycle (GO:0000083) | 2.90023505 |
60 | glycine metabolic process (GO:0006544) | 2.89327901 |
61 | regulation of ligase activity (GO:0051340) | 2.88907001 |
62 | lactate metabolic process (GO:0006089) | 2.88730373 |
63 | somatic hypermutation of immunoglobulin genes (GO:0016446) | 2.85444696 |
64 | somatic diversification of immune receptors via somatic mutation (GO:0002566) | 2.85444696 |
65 | nuclear pore complex assembly (GO:0051292) | 2.84025534 |
66 | positive regulation of ligase activity (GO:0051351) | 2.83897602 |
67 | positive regulation of interferon-beta production (GO:0032728) | 2.77394762 |
68 | mitotic recombination (GO:0006312) | 2.76878068 |
69 | heterochromatin organization (GO:0070828) | 2.76062754 |
70 | signal transduction involved in mitotic G1 DNA damage checkpoint (GO:0072431) | 2.74680733 |
71 | intracellular signal transduction involved in G1 DNA damage checkpoint (GO:1902400) | 2.74680733 |
72 | folic acid-containing compound metabolic process (GO:0006760) | 2.74609663 |
73 | regulation of translation in response to stress (GO:0043555) | 2.74447135 |
74 | signal transduction involved in mitotic DNA damage checkpoint (GO:1902402) | 2.73981356 |
75 | signal transduction involved in mitotic cell cycle checkpoint (GO:0072413) | 2.73981356 |
76 | signal transduction involved in mitotic DNA integrity checkpoint (GO:1902403) | 2.73981356 |
77 | DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest (GO:00 | 2.73945817 |
78 | DNA ligation (GO:0006266) | 2.73319721 |
79 | spindle checkpoint (GO:0031577) | 2.73083693 |
80 | protein localization to chromosome, centromeric region (GO:0071459) | 2.72838320 |
81 | signal transduction involved in DNA damage checkpoint (GO:0072422) | 2.71761068 |
82 | signal transduction involved in DNA integrity checkpoint (GO:0072401) | 2.71761068 |
83 | maturation of SSU-rRNA (GO:0030490) | 2.70861347 |
84 | chaperone-mediated protein transport (GO:0072321) | 2.70530767 |
85 | ribosome assembly (GO:0042255) | 2.70114547 |
86 | mitotic spindle checkpoint (GO:0071174) | 2.69098810 |
87 | regulation of spindle organization (GO:0090224) | 2.68595322 |
88 | metaphase plate congression (GO:0051310) | 2.67707146 |
89 | determination of adult lifespan (GO:0008340) | 2.67646031 |
90 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.67568422 |
91 | positive regulation of chromosome segregation (GO:0051984) | 2.67232639 |
92 | signal transduction involved in cell cycle checkpoint (GO:0072395) | 2.66840246 |
93 | DNA geometric change (GO:0032392) | 2.66581142 |
94 | DNA duplex unwinding (GO:0032508) | 2.65642319 |
95 | negative regulation of chromosome segregation (GO:0051985) | 2.65453150 |
96 | folic acid transport (GO:0015884) | 2.64024686 |
97 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.63792567 |
98 | spliceosomal snRNP assembly (GO:0000387) | 2.63167146 |
99 | tricarboxylic acid cycle (GO:0006099) | 2.62731154 |
100 | peptidyl-histidine modification (GO:0018202) | 2.62705794 |
101 | pentose metabolic process (GO:0019321) | 2.62171398 |
102 | establishment of chromosome localization (GO:0051303) | 2.60670703 |
103 | glycosphingolipid catabolic process (GO:0046479) | 2.60462830 |
104 | regulation of chromosome segregation (GO:0051983) | 2.60241557 |
105 | negative regulation of mitotic sister chromatid separation (GO:2000816) | 2.58950190 |
106 | negative regulation of sister chromatid segregation (GO:0033046) | 2.58950190 |
107 | negative regulation of mitotic metaphase/anaphase transition (GO:0045841) | 2.58950190 |
108 | negative regulation of metaphase/anaphase transition of cell cycle (GO:1902100) | 2.58950190 |
109 | negative regulation of mitotic sister chromatid segregation (GO:0033048) | 2.58950190 |
110 | pore complex assembly (GO:0046931) | 2.58942516 |
111 | negative regulation of gene silencing (GO:0060969) | 2.58778687 |
112 | paraxial mesoderm development (GO:0048339) | 2.58468019 |
113 | protein targeting to mitochondrion (GO:0006626) | 2.58148621 |
114 | mitotic sister chromatid segregation (GO:0000070) | 2.57031754 |
115 | pteridine-containing compound biosynthetic process (GO:0042559) | 2.57028558 |
116 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.56481231 |
117 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.56481231 |
118 | modulation by symbiont of host immune response (GO:0052553) | 2.56481231 |
119 | positive regulation by symbiont of host defense response (GO:0052509) | 2.56481231 |
120 | modulation by symbiont of host defense response (GO:0052031) | 2.56481231 |
121 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.56481231 |
122 | telomere maintenance via telomere lengthening (GO:0010833) | 2.56108227 |
123 | negative regulation of protein ubiquitination (GO:0031397) | 2.55828752 |
124 | sister chromatid segregation (GO:0000819) | 2.55036440 |
125 | positive regulation of interferon-alpha production (GO:0032727) | 2.55034058 |
126 | nuclear envelope organization (GO:0006998) | 2.54000248 |
127 | pyrimidine nucleoside triphosphate biosynthetic process (GO:0009148) | 2.53396056 |
128 | L-alpha-amino acid transmembrane transport (GO:1902475) | 2.52452585 |
129 | pentose-phosphate shunt (GO:0006098) | 2.52249473 |
130 | histone arginine methylation (GO:0034969) | 2.51287916 |
131 | neutrophil activation involved in immune response (GO:0002283) | 2.50823639 |
132 | positive regulation of SMAD protein import into nucleus (GO:0060391) | 2.49039851 |
133 | DNA deamination (GO:0045006) | 2.42995638 |
134 | attachment of spindle microtubules to kinetochore (GO:0008608) | 2.42776622 |
135 | regulation of telomere maintenance via telomerase (GO:0032210) | 2.42212419 |
136 | antigen processing and presentation of exogenous peptide antigen via MHC class I (GO:0042590) | 2.40969010 |
137 | anaphase-promoting complex-dependent proteasomal ubiquitin-dependent protein catabolic process (GO:0 | 2.40688900 |
138 | regulation of interferon-alpha production (GO:0032647) | 2.40617636 |
139 | pinocytosis (GO:0006907) | 2.39523211 |
140 | regulation of mitotic spindle organization (GO:0060236) | 2.38700402 |
141 | serine family amino acid biosynthetic process (GO:0009070) | 2.37411621 |
142 | termination of RNA polymerase III transcription (GO:0006386) | 2.37281017 |
143 | transcription elongation from RNA polymerase III promoter (GO:0006385) | 2.37281017 |
144 | mRNA cleavage (GO:0006379) | 2.36917355 |
145 | regulation of translational fidelity (GO:0006450) | 2.36735353 |
146 | nucleotide-excision repair, DNA gap filling (GO:0006297) | 2.36544161 |
147 | regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051439) | 2.36101743 |
148 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-dependent (GO: | 2.35331854 |
149 | aspartate family amino acid biosynthetic process (GO:0009067) | 2.35044290 |
150 | regulation of helicase activity (GO:0051095) | 2.34835553 |
151 | transcription-coupled nucleotide-excision repair (GO:0006283) | 2.34493939 |
152 | negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051436) | 2.34186720 |
153 | cell cycle G1/S phase transition (GO:0044843) | 2.33523117 |
154 | G1/S transition of mitotic cell cycle (GO:0000082) | 2.33523117 |
155 | telomere maintenance (GO:0000723) | 2.33160347 |
156 | telomere organization (GO:0032200) | 2.32842630 |
157 | positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle (GO:0051437) | 2.31557038 |
158 | sulfur amino acid biosynthetic process (GO:0000097) | 2.31256305 |
159 | pteridine-containing compound metabolic process (GO:0042558) | 2.30808230 |
160 | serine family amino acid metabolic process (GO:0009069) | 2.30622787 |
161 | positive regulation of protein import into nucleus, translocation (GO:0033160) | 2.30182856 |
162 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.28609587 |
163 | tRNA aminoacylation for protein translation (GO:0006418) | 2.28310077 |
164 | maintenance of fidelity involved in DNA-dependent DNA replication (GO:0045005) | 2.27991204 |
165 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 2.26744085 |
166 | regulation of interferon-beta production (GO:0032648) | 2.26340383 |
Rank | Gene Set | Z-score |
---|---|---|
1 | E2F7_22180533_ChIP-Seq_HELA_Human | 7.12766390 |
2 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 3.32009988 |
3 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 3.17768021 |
4 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 2.80410648 |
5 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.55125337 |
6 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 2.54879704 |
7 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 2.35097093 |
8 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.33001262 |
9 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 2.28735048 |
10 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 2.28660252 |
11 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.28299377 |
12 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 2.26609451 |
13 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.25981089 |
14 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.25699786 |
15 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.07636234 |
16 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 2.07587279 |
17 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 2.04871529 |
18 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.01990541 |
19 | NELFA_20434984_ChIP-Seq_ESCs_Mouse | 2.01305996 |
20 | POU5F1_18700969_ChIP-ChIP_MESCs_Mouse | 1.99115892 |
21 | NANOG_18555785_ChIP-Seq_MESCs_Mouse | 1.91302373 |
22 | * E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.88093982 |
23 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.82663877 |
24 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.81984929 |
25 | CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.81833985 |
26 | MYBL1_21750041_ChIP-ChIP_SPERMATOCYTES_Mouse | 1.80132141 |
27 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.78391211 |
28 | POU5F1_18555785_ChIP-Seq_MESCs_Mouse | 1.72689517 |
29 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.72501212 |
30 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 1.70982870 |
31 | * TFEB_21752829_ChIP-Seq_HELA_Human | 1.68908964 |
32 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.68803930 |
33 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 1.61130553 |
34 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.60701183 |
35 | SMAD1_18555785_ChIP-Seq_MESCs_Mouse | 1.59825074 |
36 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 1.57830869 |
37 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.55980994 |
38 | MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.54980303 |
39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.54507710 |
40 | MYC_22102868_ChIP-Seq_BL_Human | 1.52232577 |
41 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.51465701 |
42 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.50071812 |
43 | GABP_19822575_ChIP-Seq_HepG2_Human | 1.48486199 |
44 | MYBL2_22936984_ChIP-ChIP_MESCs_Mouse | 1.48476063 |
45 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.47484336 |
46 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.44466845 |
47 | PADI4_21655091_ChIP-ChIP_MCF-7_Human | 1.42640808 |
48 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.42240182 |
49 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.40770290 |
50 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38703594 |
51 | SOX17_20123909_ChIP-Seq_XEN_Mouse | 1.38685603 |
52 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.37717600 |
53 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.37631069 |
54 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.37541284 |
55 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 1.36955313 |
56 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.36291015 |
57 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.36181415 |
58 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.34963671 |
59 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.34947250 |
60 | NANOG_18700969_ChIP-ChIP_MESCs_Mouse | 1.33277490 |
61 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.33175262 |
62 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.32967698 |
63 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.32561865 |
64 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.31706002 |
65 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.29293828 |
66 | YY1_21170310_ChIP-Seq_MESCs_Mouse | 1.28943955 |
67 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.28901757 |
68 | NACC1_18358816_ChIP-ChIP_MESCs_Mouse | 1.27785893 |
69 | * CREB1_23762244_ChIP-Seq_HIPPOCAMPUS_Rat | 1.27532763 |
70 | KLF2_18264089_ChIP-ChIP_MESCs_Mouse | 1.24961896 |
71 | KLF5_18264089_ChIP-ChIP_MESCs_Mouse | 1.24961896 |
72 | KLF4_18264089_ChIP-ChIP_MESCs_Mouse | 1.24961896 |
73 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.24447747 |
74 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.23919328 |
75 | * KDM5B_21448134_ChIP-Seq_MESCs_Mouse | 1.23059544 |
76 | CREM_20920259_ChIP-Seq_GC1-SPG_Mouse | 1.23028241 |
77 | TCF3_18692474_ChIP-Seq_MEFs_Mouse | 1.21731634 |
78 | POU5F1_18358816_ChIP-ChIP_MESCs_Mouse | 1.21689643 |
79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.21639143 |
80 | ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.21330918 |
81 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.21310407 |
82 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.21226306 |
83 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.19172337 |
84 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.19104887 |
85 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.18901926 |
86 | * KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.18552084 |
87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.16378269 |
88 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.14088130 |
89 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.13863112 |
90 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.12596640 |
91 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.11654587 |
92 | ELK1_22589737_ChIP-Seq_MCF10A_Human | 1.11045522 |
93 | * ASH2L_23239880_ChIP-Seq_MESCs_Mouse | 1.10903290 |
94 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.10055677 |
95 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.10017216 |
96 | YY1_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.09665049 |
97 | MYCN_21190229_ChIP-Seq_SHEP-21N_Human | 1.08874981 |
98 | HOXC9_25013753_ChIP-Seq_NEUROBLASTOMA_BE2-C_Human | 1.08527637 |
99 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.08226654 |
100 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.08122264 |
101 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06247543 |
102 | NANOG_21062744_ChIP-ChIP_HESCs_Human | 1.05884884 |
103 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 1.05192780 |
104 | SOX2_18555785_ChIP-Seq_MESCs_Mouse | 1.03887572 |
105 | NANOG_18358816_ChIP-ChIP_MESCs_Mouse | 1.03600432 |
106 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.01913280 |
107 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.01717107 |
108 | SOX2_18692474_ChIP-Seq_MEFs_Mouse | 1.01630561 |
109 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.01455413 |
110 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.00699049 |
111 | SIN3A_21632747_ChIP-Seq_MESCs_Mouse | 1.00578126 |
112 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.00414089 |
113 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 0.99906711 |
114 | KLF4_19030024_ChIP-ChIP_MESCs_Mouse | 0.99826309 |
115 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98153736 |
116 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.98030138 |
117 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 0.97957232 |
118 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.97566538 |
119 | OCT4_18692474_ChIP-Seq_MEFs_Mouse | 0.97506423 |
120 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 0.97161908 |
121 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.97089802 |
122 | * TRIM28_19339689_ChIP-ChIP_MESCs_Mouse | 0.96937193 |
123 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 0.96570252 |
124 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 0.96361301 |
125 | EOMES_20176728_ChIP-ChIP_TSCs_Mouse | 0.96279443 |
126 | CREB1_20920259_ChIP-Seq_GC1-SPG_Mouse | 0.95300765 |
127 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 0.95104894 |
128 | E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 0.94791342 |
129 | NANOG_16153702_ChIP-ChIP_HESCs_Human | 0.94594485 |
130 | CLOCK_20551151_ChIP-Seq_293T_Human | 0.93938349 |
131 | MYC_18940864_ChIP-ChIP_HL60_Human | 0.92337291 |
132 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.91696071 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MP0003693_abnormal_embryo_hatching | 3.49850561 |
2 | MP0003111_abnormal_nucleus_morphology | 3.23387373 |
3 | MP0005058_abnormal_lysosome_morphology | 3.17569263 |
4 | MP0003806_abnormal_nucleotide_metabolis | 3.06010469 |
5 | MP0009840_abnormal_foam_cell | 3.01611199 |
6 | MP0008057_abnormal_DNA_replication | 2.97570819 |
7 | MP0004957_abnormal_blastocyst_morpholog | 2.92783294 |
8 | MP0002254_reproductive_system_inflammat | 2.92294584 |
9 | MP0010094_abnormal_chromosome_stability | 2.86826568 |
10 | MP0010030_abnormal_orbit_morphology | 2.54474675 |
11 | MP0003077_abnormal_cell_cycle | 2.52188114 |
12 | MP0003172_abnormal_lysosome_physiology | 2.40615418 |
13 | MP0003941_abnormal_skin_development | 2.36513150 |
14 | MP0001835_abnormal_antigen_presentation | 2.36191042 |
15 | MP0010307_abnormal_tumor_latency | 2.32807292 |
16 | MP0002090_abnormal_vision | 2.12589647 |
17 | MP0008058_abnormal_DNA_repair | 2.10713521 |
18 | MP0005408_hypopigmentation | 2.06353853 |
19 | MP0003136_yellow_coat_color | 2.01446931 |
20 | MP0003186_abnormal_redox_activity | 2.00104386 |
21 | MP0002396_abnormal_hematopoietic_system | 1.96384348 |
22 | MP0010352_gastrointestinal_tract_polyps | 1.85938773 |
23 | MP0005257_abnormal_intraocular_pressure | 1.84456901 |
24 | MP0008007_abnormal_cellular_replicative | 1.84108733 |
25 | MP0003436_decreased_susceptibility_to | 1.81201658 |
26 | MP0006082_CNS_inflammation | 1.78677550 |
27 | MP0002938_white_spotting | 1.70626772 |
28 | MP0005360_urolithiasis | 1.63880303 |
29 | MP0009333_abnormal_splenocyte_physiolog | 1.62756333 |
30 | MP0009697_abnormal_copulation | 1.62178447 |
31 | MP0005671_abnormal_response_to | 1.61604584 |
32 | MP0005248_abnormal_Harderian_gland | 1.58739068 |
33 | MP0009672_abnormal_birth_weight | 1.58507211 |
34 | MP0000689_abnormal_spleen_morphology | 1.57141073 |
35 | MP0002419_abnormal_innate_immunity | 1.55502808 |
36 | MP0006035_abnormal_mitochondrial_morpho | 1.55254188 |
37 | MP0005171_absent_coat_pigmentation | 1.53569402 |
38 | MP0001730_embryonic_growth_arrest | 1.53143065 |
39 | MP0002697_abnormal_eye_size | 1.50893367 |
40 | MP0003566_abnormal_cell_adhesion | 1.49969371 |
41 | MP0002877_abnormal_melanocyte_morpholog | 1.48044937 |
42 | MP0000490_abnormal_crypts_of | 1.46093317 |
43 | MP0002722_abnormal_immune_system | 1.44254439 |
44 | MP0000350_abnormal_cell_proliferation | 1.44011669 |
45 | MP0008260_abnormal_autophagy | 1.43756222 |
46 | MP0002452_abnormal_antigen_presenting | 1.42151388 |
47 | MP0005397_hematopoietic_system_phenotyp | 1.42100314 |
48 | MP0001545_abnormal_hematopoietic_system | 1.42100314 |
49 | MP0010234_abnormal_vibrissa_follicle | 1.40234575 |
50 | MP0002398_abnormal_bone_marrow | 1.39207910 |
51 | MP0002148_abnormal_hypersensitivity_rea | 1.38545877 |
52 | MP0000858_altered_metastatic_potential | 1.38386753 |
53 | MP0005025_abnormal_response_to | 1.37936119 |
54 | MP0001293_anophthalmia | 1.37060619 |
55 | MP0002138_abnormal_hepatobiliary_system | 1.36575077 |
56 | MP0000537_abnormal_urethra_morphology | 1.36547336 |
57 | MP0001800_abnormal_humoral_immune | 1.36483455 |
58 | MP0005000_abnormal_immune_tolerance | 1.35984897 |
59 | MP0002084_abnormal_developmental_patter | 1.35347977 |
60 | MP0000647_abnormal_sebaceous_gland | 1.34976070 |
61 | MP0001849_ear_inflammation | 1.33846142 |
62 | MP0009785_altered_susceptibility_to | 1.31755017 |
63 | MP0001661_extended_life_span | 1.31627307 |
64 | MP0003191_abnormal_cellular_cholesterol | 1.30761944 |
65 | MP0006292_abnormal_olfactory_placode | 1.30749580 |
66 | MP0002085_abnormal_embryonic_tissue | 1.30167685 |
67 | MP0000685_abnormal_immune_system | 1.30062806 |
68 | MP0002019_abnormal_tumor_incidence | 1.28668481 |
69 | MP0002723_abnormal_immune_serum | 1.27213751 |
70 | MP0004264_abnormal_extraembryonic_tissu | 1.27075600 |
71 | MP0004133_heterotaxia | 1.26887427 |
72 | MP0004019_abnormal_vitamin_homeostasis | 1.26807092 |
73 | MP0000428_abnormal_craniofacial_morphol | 1.26281628 |
74 | MP0001819_abnormal_immune_cell | 1.25380521 |
75 | MP0002420_abnormal_adaptive_immunity | 1.25253730 |
76 | MP0008932_abnormal_embryonic_tissue | 1.24571166 |
77 | MP0002429_abnormal_blood_cell | 1.21984791 |
78 | MP0002163_abnormal_gland_morphology | 1.21808155 |
79 | MP0000313_abnormal_cell_death | 1.21242489 |
80 | MP0002405_respiratory_system_inflammati | 1.20797349 |
81 | MP0003448_altered_tumor_morphology | 1.20639173 |
82 | MP0005332_abnormal_amino_acid | 1.20180004 |
83 | MP0000716_abnormal_immune_system | 1.19756431 |
84 | MP0000371_diluted_coat_color | 1.19029700 |
85 | MP0006054_spinal_hemorrhage | 1.18752867 |
86 | MP0003567_abnormal_fetal_cardiomyocyte | 1.17955570 |
87 | MP0005379_endocrine/exocrine_gland_phen | 1.16676042 |
88 | MP0001915_intracranial_hemorrhage | 1.16558476 |
89 | MP0009643_abnormal_urine_homeostasis | 1.16010584 |
90 | MP0002233_abnormal_nose_morphology | 1.15225703 |
91 | MP0005464_abnormal_platelet_physiology | 1.15166734 |
92 | MP0005451_abnormal_body_composition | 1.15158182 |
93 | MP0005387_immune_system_phenotype | 1.14839011 |
94 | MP0001790_abnormal_immune_system | 1.14839011 |
95 | MP0001853_heart_inflammation | 1.14773387 |
96 | MP0004233_abnormal_muscle_weight | 1.12347919 |
97 | MP0005197_abnormal_uvea_morphology | 1.10437869 |
98 | MP0002092_abnormal_eye_morphology | 1.10305246 |
99 | MP0000358_abnormal_cell_content/ | 1.10198415 |
100 | MP0004272_abnormal_basement_membrane | 1.09637930 |
101 | MP0001324_abnormal_eye_pigmentation | 1.08829995 |
102 | MP0002111_abnormal_tail_morphology | 1.08220064 |
103 | MP0003221_abnormal_cardiomyocyte_apopto | 1.07788118 |
104 | MP0002086_abnormal_extraembryonic_tissu | 1.07496557 |
105 | MP0008789_abnormal_olfactory_epithelium | 1.07183630 |
106 | MP0001845_abnormal_inflammatory_respons | 1.06815578 |
107 | MP0001984_abnormal_olfaction | 1.06610578 |
108 | MP0003937_abnormal_limbs/digits/tail_de | 1.06518768 |
109 | MP0002080_prenatal_lethality | 1.05929961 |
110 | MP0008469_abnormal_protein_level | 1.05757453 |
111 | MP0003890_abnormal_embryonic-extraembry | 1.05595198 |
112 | MP0001299_abnormal_eye_distance/ | 1.05093055 |
113 | MP0001672_abnormal_embryogenesis/_devel | 1.04862983 |
114 | MP0005380_embryogenesis_phenotype | 1.04862983 |
115 | MP0001697_abnormal_embryo_size | 1.04625338 |
116 | MP0000598_abnormal_liver_morphology | 1.03915908 |
117 | MP0003786_premature_aging | 1.03737132 |
118 | MP0006072_abnormal_retinal_apoptosis | 1.03404573 |
119 | MP0000372_irregular_coat_pigmentation | 1.01249527 |
120 | MP0005076_abnormal_cell_differentiation | 1.00716730 |
121 | MP0009053_abnormal_anal_canal | 1.00708660 |
122 | MP0003984_embryonic_growth_retardation | 1.00543191 |
123 | MP0004808_abnormal_hematopoietic_stem | 0.99639687 |
124 | MP0000609_abnormal_liver_physiology | 0.99162163 |
125 | MP0008877_abnormal_DNA_methylation | 0.98411184 |
126 | MP0002638_abnormal_pupillary_reflex | 0.98108682 |
127 | MP0005319_abnormal_enzyme/_coenzyme | 0.97895558 |
128 | MP0002088_abnormal_embryonic_growth/wei | 0.97881941 |
129 | MP0003656_abnormal_erythrocyte_physiolo | 0.97506464 |
130 | MP0003718_maternal_effect | 0.97281494 |
131 | MP0001727_abnormal_embryo_implantation | 0.95572752 |
132 | MP0000343_altered_response_to | 0.94751038 |
133 | MP0000703_abnormal_thymus_morphology | 0.94267873 |
134 | MP0002139_abnormal_hepatobiliary_system | 0.92886654 |
135 | MP0001764_abnormal_homeostasis | 0.92641076 |
136 | MP0003315_abnormal_perineum_morphology | 0.92470663 |
137 | MP0006036_abnormal_mitochondrial_physio | 0.92427807 |
138 | MP0002136_abnormal_kidney_physiology | 0.90895124 |
139 | MP0005310_abnormal_salivary_gland | 0.85483656 |
140 | MP0005193_abnormal_anterior_eye | 0.84578135 |
141 | MP0005391_vision/eye_phenotype | 0.84077549 |
142 | MP0005394_taste/olfaction_phenotype | 0.84076395 |
143 | MP0005499_abnormal_olfactory_system | 0.84076395 |
144 | MP0010155_abnormal_intestine_physiology | 0.82918657 |
145 | MP0003303_peritoneal_inflammation | 0.82825739 |
146 | MP0004197_abnormal_fetal_growth/weight/ | 0.82084710 |
147 | MP0003763_abnormal_thymus_physiology | 0.81817397 |
148 | MP0003123_paternal_imprinting | 0.81809256 |
149 | MP0002132_abnormal_respiratory_system | 0.81756003 |
150 | MP0005384_cellular_phenotype | 0.81652938 |
151 | MP0005621_abnormal_cell_physiology | 0.81554354 |
152 | MP0000566_synostosis | 0.81093387 |
153 | MP0003755_abnormal_palate_morphology | 0.80984345 |
154 | MP0009703_decreased_birth_body | 0.80648947 |
155 | MP0005023_abnormal_wound_healing | 0.79737981 |
156 | MP0003634_abnormal_glial_cell | 0.78765142 |
157 | MP0005365_abnormal_bile_salt | 0.77438436 |
158 | MP0005377_hearing/vestibular/ear_phenot | 0.77429300 |
159 | MP0001186_pigmentation_phenotype | 0.75238987 |
160 | MP0003011_delayed_dark_adaptation | 0.74654187 |
161 | MP0000579_abnormal_nail_morphology | 0.73228483 |
162 | MP0002210_abnormal_sex_determination | 0.71709494 |
163 | MP0003453_abnormal_keratinocyte_physiol | 0.71495342 |
164 | MP0005501_abnormal_skin_physiology | 0.71408364 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Agnosia (HP:0010524) | 4.83686120 |
2 | Vacuolated lymphocytes (HP:0001922) | 4.31811832 |
3 | Birth length less than 3rd percentile (HP:0003561) | 3.43719696 |
4 | Increased cerebral lipofuscin (HP:0011813) | 3.31806052 |
5 | Abnormality of glycolysis (HP:0004366) | 3.28847872 |
6 | Abnormality of macrophages (HP:0004311) | 3.24547471 |
7 | Recurrent abscess formation (HP:0002722) | 3.23685394 |
8 | Hypokinesia (HP:0002375) | 3.16753839 |
9 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.12317404 |
10 | Abnormality of the anterior horn cell (HP:0006802) | 3.11963506 |
11 | Degeneration of anterior horn cells (HP:0002398) | 3.11963506 |
12 | Nuclear cataract (HP:0100018) | 3.11949835 |
13 | Increased serum pyruvate (HP:0003542) | 3.00995862 |
14 | Spinal muscular atrophy (HP:0007269) | 2.85646590 |
15 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.85492149 |
16 | Spastic diplegia (HP:0001264) | 2.83398900 |
17 | Personality changes (HP:0000751) | 2.82071740 |
18 | Dysostosis multiplex (HP:0000943) | 2.80269006 |
19 | Systemic lupus erythematosus (HP:0002725) | 2.79407250 |
20 | Cerebral hypomyelination (HP:0006808) | 2.78015818 |
21 | IgM deficiency (HP:0002850) | 2.77446301 |
22 | Multiple enchondromatosis (HP:0005701) | 2.72534879 |
23 | Tongue fasciculations (HP:0001308) | 2.71075376 |
24 | Vertebral compression fractures (HP:0002953) | 2.69406141 |
25 | Breast hypoplasia (HP:0003187) | 2.68194690 |
26 | Microvesicular hepatic steatosis (HP:0001414) | 2.67483826 |
27 | Acute encephalopathy (HP:0006846) | 2.67333726 |
28 | Acute necrotizing encephalopathy (HP:0006965) | 2.66350823 |
29 | Carpal bone hypoplasia (HP:0001498) | 2.62975735 |
30 | Increased hepatocellular lipid droplets (HP:0006565) | 2.60213220 |
31 | Ependymoma (HP:0002888) | 2.60054804 |
32 | Upper motor neuron abnormality (HP:0002127) | 2.59849215 |
33 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.54335178 |
34 | Chromsome breakage (HP:0040012) | 2.53569199 |
35 | Recurrent bacterial skin infections (HP:0005406) | 2.50966867 |
36 | Medulloblastoma (HP:0002885) | 2.50214212 |
37 | Aplastic anemia (HP:0001915) | 2.48516886 |
38 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.48238574 |
39 | Abnormality of glycolipid metabolism (HP:0010969) | 2.48238574 |
40 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.48238574 |
41 | Lipid accumulation in hepatocytes (HP:0006561) | 2.48001871 |
42 | Patchy hypopigmentation of hair (HP:0011365) | 2.46866757 |
43 | Nausea (HP:0002018) | 2.45598873 |
44 | Esophageal neoplasm (HP:0100751) | 2.44083808 |
45 | Neoplasm of head and neck (HP:0012288) | 2.44083808 |
46 | Hypoglycemic coma (HP:0001325) | 2.43821513 |
47 | Autoimmune thrombocytopenia (HP:0001973) | 2.43624869 |
48 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.43509083 |
49 | Hyperglycinuria (HP:0003108) | 2.42005588 |
50 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 2.40059201 |
51 | Abnormality of methionine metabolism (HP:0010901) | 2.36538035 |
52 | Hypoglycemic seizures (HP:0002173) | 2.36531676 |
53 | Mucopolysacchariduria (HP:0008155) | 2.35695784 |
54 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.35695784 |
55 | Loss of speech (HP:0002371) | 2.34064142 |
56 | Secondary amenorrhea (HP:0000869) | 2.33679002 |
57 | Abnormality of chromosome stability (HP:0003220) | 2.33166237 |
58 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 2.32375336 |
59 | Abnormal gallbladder physiology (HP:0012438) | 2.32191190 |
60 | Cholecystitis (HP:0001082) | 2.32191190 |
61 | Muscle fibrillation (HP:0010546) | 2.31949477 |
62 | Poor head control (HP:0002421) | 2.31680334 |
63 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.31646726 |
64 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.31646726 |
65 | Chromosomal breakage induced by crosslinking agents (HP:0003221) | 2.31386088 |
66 | Colon cancer (HP:0003003) | 2.29611748 |
67 | Rough bone trabeculation (HP:0100670) | 2.28728908 |
68 | Impulsivity (HP:0100710) | 2.27623821 |
69 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.27242037 |
70 | Symptomatic seizures (HP:0011145) | 2.25773560 |
71 | Eczematoid dermatitis (HP:0000976) | 2.25552660 |
72 | Rhabdomyosarcoma (HP:0002859) | 2.19356027 |
73 | White forelock (HP:0002211) | 2.19341490 |
74 | Postnatal microcephaly (HP:0005484) | 2.18538138 |
75 | Increased CSF lactate (HP:0002490) | 2.14934931 |
76 | Metaphyseal cupping (HP:0003021) | 2.13802350 |
77 | Myelodysplasia (HP:0002863) | 2.11797320 |
78 | Amaurosis fugax (HP:0100576) | 2.10673964 |
79 | Abnormal neuron morphology (HP:0012757) | 2.10594914 |
80 | Abnormality of the motor neurons (HP:0002450) | 2.10594914 |
81 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.10166898 |
82 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.10166898 |
83 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.10166898 |
84 | Hand muscle atrophy (HP:0009130) | 2.07283979 |
85 | Renal Fanconi syndrome (HP:0001994) | 2.06911221 |
86 | Abnormal lung lobation (HP:0002101) | 2.05807583 |
87 | Anorexia (HP:0002039) | 2.03313605 |
88 | Thrombocytosis (HP:0001894) | 2.03020692 |
89 | Abnormality of the labia minora (HP:0012880) | 2.02574520 |
90 | Progressive macrocephaly (HP:0004481) | 2.01956480 |
91 | Adrenal hypoplasia (HP:0000835) | 2.01649889 |
92 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.01091116 |
93 | Neoplasm of the adrenal gland (HP:0100631) | 1.98560078 |
94 | Abnormality of sulfur amino acid metabolism (HP:0004339) | 1.98449061 |
95 | Bone marrow hypocellularity (HP:0005528) | 1.98324352 |
96 | Prominent metopic ridge (HP:0005487) | 1.98276463 |
97 | Megaloblastic anemia (HP:0001889) | 1.96820264 |
98 | Petechiae (HP:0000967) | 1.96533071 |
99 | Cerebral edema (HP:0002181) | 1.95270891 |
100 | Reticulocytopenia (HP:0001896) | 1.94033045 |
101 | Type I transferrin isoform profile (HP:0003642) | 1.93574817 |
102 | Respiratory failure (HP:0002878) | 1.92666118 |
103 | Urticaria (HP:0001025) | 1.92437239 |
104 | Mitochondrial inheritance (HP:0001427) | 1.91745381 |
105 | Atrophy/Degeneration involving motor neurons (HP:0007373) | 1.91153003 |
106 | Abnormality of the metopic suture (HP:0005556) | 1.91022232 |
107 | Axonal loss (HP:0003447) | 1.90992074 |
108 | Disinhibition (HP:0000734) | 1.90720668 |
109 | Apathy (HP:0000741) | 1.90297879 |
110 | Prolonged neonatal jaundice (HP:0006579) | 1.89121815 |
111 | Pustule (HP:0200039) | 1.87281635 |
112 | Pathologic fracture (HP:0002756) | 1.86879305 |
113 | Fasciculations (HP:0002380) | 1.86577741 |
114 | Tetraparesis (HP:0002273) | 1.86076878 |
115 | Abnormal trabecular bone morphology (HP:0100671) | 1.85288390 |
116 | Abnormality of nucleobase metabolism (HP:0010932) | 1.85223117 |
117 | Hyperglycinemia (HP:0002154) | 1.84571855 |
118 | Diminished motivation (HP:0000745) | 1.84553450 |
119 | Mediastinal lymphadenopathy (HP:0100721) | 1.84437487 |
120 | Oral leukoplakia (HP:0002745) | 1.84387752 |
121 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 1.84336409 |
122 | Angiofibromas (HP:0010615) | 1.83870926 |
123 | Adenoma sebaceum (HP:0009720) | 1.83870926 |
124 | Recurrent viral infections (HP:0004429) | 1.83281383 |
125 | Meckel diverticulum (HP:0002245) | 1.82102870 |
126 | Cortical dysplasia (HP:0002539) | 1.81676651 |
127 | Premature ovarian failure (HP:0008209) | 1.81516770 |
128 | Recurrent fungal infections (HP:0002841) | 1.81486070 |
129 | Myositis (HP:0100614) | 1.79430015 |
130 | Gout (HP:0001997) | 1.79285578 |
131 | Dysphonia (HP:0001618) | 1.78153987 |
132 | Abnormality of glycine metabolism (HP:0010895) | 1.78147323 |
133 | Abnormality of serine family amino acid metabolism (HP:0010894) | 1.78147323 |
134 | Abnormality of long-chain fatty-acid metabolism (HP:0010964) | 1.78058412 |
135 | Progressive neurologic deterioration (HP:0002344) | 1.77477620 |
136 | Abnormality of the ileum (HP:0001549) | 1.77402344 |
137 | Posterior subcapsular cataract (HP:0007787) | 1.77247702 |
138 | Cervical subluxation (HP:0003308) | 1.77105556 |
139 | Delayed puberty (HP:0000823) | 1.74207787 |
140 | Increased serum lactate (HP:0002151) | 1.73781598 |
141 | Increased serum ferritin (HP:0003281) | 1.73481476 |
142 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.73217414 |
143 | Trismus (HP:0000211) | 1.73179973 |
144 | Sensorimotor neuropathy (HP:0007141) | 1.72890744 |
145 | Progressive muscle weakness (HP:0003323) | 1.72708395 |
146 | Selective tooth agenesis (HP:0001592) | 1.71289554 |
147 | Abnormality of iron homeostasis (HP:0011031) | 1.70977396 |
148 | Abnormality of lateral ventricle (HP:0030047) | 1.70865730 |
149 | Conjunctival telangiectasia (HP:0000524) | 1.70785989 |
150 | Abnormality of transition element cation homeostasis (HP:0011030) | 1.70683332 |
151 | Zonular cataract (HP:0010920) | 1.70570701 |
152 | Lymphoma (HP:0002665) | 1.69828360 |
153 | Upper limb muscle weakness (HP:0003484) | 1.69737994 |
154 | Lactic acidosis (HP:0003128) | 1.68908960 |
155 | Abnormal cartilage morphology (HP:0002763) | 1.68240268 |
156 | Aplasia/Hypoplasia of the uvula (HP:0010293) | 1.67981928 |
157 | Pancytopenia (HP:0001876) | 1.67916073 |
158 | Abnormality of aspartate family amino acid metabolism (HP:0010899) | 1.67648617 |
159 | Abnormality of the preputium (HP:0100587) | 1.67384808 |
160 | Astrocytoma (HP:0009592) | 1.67250841 |
161 | Abnormality of the astrocytes (HP:0100707) | 1.67250841 |
162 | Hypoplastic pelvis (HP:0008839) | 1.66933320 |
163 | Shoulder girdle muscle weakness (HP:0003547) | 1.66463846 |
164 | Neoplasm of the rectum (HP:0100743) | 1.65863435 |
165 | Progressive external ophthalmoplegia (HP:0000590) | 1.64116075 |
166 | Sparse eyelashes (HP:0000653) | 1.64010744 |
167 | Beaking of vertebral bodies (HP:0004568) | 1.63968935 |
168 | Exercise intolerance (HP:0003546) | 1.63712772 |
169 | Overlapping toe (HP:0001845) | 1.63094495 |
170 | Abnormal protein glycosylation (HP:0012346) | 1.61415390 |
171 | Abnormal glycosylation (HP:0012345) | 1.61415390 |
172 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 1.61415390 |
173 | Abnormal protein N-linked glycosylation (HP:0012347) | 1.61415390 |
174 | Microglossia (HP:0000171) | 1.60278748 |
175 | CNS hypomyelination (HP:0003429) | 1.59650434 |
Rank | Gene Set | Z-score |
---|---|---|
1 | WEE1 | 4.23939130 |
2 | PBK | 4.05262939 |
3 | BUB1 | 3.49017853 |
4 | STK10 | 3.26263157 |
5 | CDC7 | 2.92646303 |
6 | BRSK2 | 2.60928232 |
7 | NEK1 | 2.60472072 |
8 | STK16 | 2.33489002 |
9 | EIF2AK1 | 2.27496622 |
10 | FLT3 | 2.27345852 |
11 | VRK2 | 2.16060770 |
12 | ERBB4 | 2.10717054 |
13 | ACVR1B | 2.08927358 |
14 | TSSK6 | 2.05623849 |
15 | NME2 | 2.04569860 |
16 | NEK2 | 1.97064900 |
17 | CDK12 | 1.81246670 |
18 | PIM2 | 1.81021761 |
19 | MAP3K8 | 1.74398786 |
20 | TTK | 1.68631680 |
21 | MAP4K1 | 1.67338833 |
22 | MAP2K3 | 1.60117044 |
23 | LIMK1 | 1.58612025 |
24 | BLK | 1.58288833 |
25 | PLK1 | 1.53719983 |
26 | EPHA2 | 1.53372207 |
27 | TESK2 | 1.52229951 |
28 | PAK4 | 1.49662968 |
29 | LRRK2 | 1.45631864 |
30 | TRIM28 | 1.42317391 |
31 | KIT | 1.40414173 |
32 | ATR | 1.33685166 |
33 | GRK6 | 1.32604414 |
34 | SRPK1 | 1.29597617 |
35 | MAP3K10 | 1.29000652 |
36 | PASK | 1.28106456 |
37 | SCYL2 | 1.26903030 |
38 | PIM1 | 1.25458506 |
39 | ZAP70 | 1.23266540 |
40 | ERN1 | 1.21316836 |
41 | CDK7 | 1.20921801 |
42 | CSNK1G3 | 1.20332579 |
43 | AKT3 | 1.18728690 |
44 | MKNK1 | 1.18328145 |
45 | CSNK1G1 | 1.18319623 |
46 | BCKDK | 1.18151100 |
47 | PLK3 | 1.17532055 |
48 | TYK2 | 1.16886342 |
49 | BRSK1 | 1.16159934 |
50 | EIF2AK3 | 1.15994788 |
51 | TBK1 | 1.15757894 |
52 | CDK4 | 1.09622288 |
53 | RPS6KA4 | 1.08972549 |
54 | MST1R | 1.05288304 |
55 | TESK1 | 1.05281451 |
56 | STK4 | 1.04858934 |
57 | IRAK3 | 1.01171593 |
58 | PLK4 | 1.00510706 |
59 | PTK2 | 0.99627564 |
60 | MAP3K3 | 0.99256338 |
61 | CSNK1G2 | 0.98636972 |
62 | MAP3K14 | 0.98228949 |
63 | RPS6KB2 | 0.98114661 |
64 | CSNK1A1L | 0.97743518 |
65 | CSF1R | 0.92414106 |
66 | BCR | 0.91832282 |
67 | LATS2 | 0.91563634 |
68 | TRIB3 | 0.89921990 |
69 | PDK2 | 0.89611785 |
70 | AURKB | 0.89243256 |
71 | ERBB3 | 0.88422803 |
72 | JAK3 | 0.88182566 |
73 | IRAK4 | 0.87277062 |
74 | ABL2 | 0.86096916 |
75 | TAOK3 | 0.85483353 |
76 | PKN2 | 0.85026770 |
77 | PDK3 | 0.84922546 |
78 | PDK4 | 0.84922546 |
79 | DYRK3 | 0.84505575 |
80 | TAF1 | 0.84235965 |
81 | TLK1 | 0.83805894 |
82 | MAP3K11 | 0.83058270 |
83 | MET | 0.82416011 |
84 | CLK1 | 0.81932164 |
85 | TGFBR1 | 0.81781185 |
86 | DAPK1 | 0.80792584 |
87 | MKNK2 | 0.79926029 |
88 | CCNB1 | 0.78835140 |
89 | PLK2 | 0.75092946 |
90 | MAP2K7 | 0.74217231 |
91 | MATK | 0.73929175 |
92 | CHEK2 | 0.73711850 |
93 | KDR | 0.72226938 |
94 | MST4 | 0.71030411 |
95 | PDGFRA | 0.70940327 |
96 | MAP3K4 | 0.70186655 |
97 | TGFBR2 | 0.68956396 |
98 | EPHA4 | 0.68806128 |
99 | SMG1 | 0.68552028 |
100 | STK3 | 0.67830805 |
101 | CHEK1 | 0.66628140 |
102 | RIPK1 | 0.65633502 |
103 | EPHB2 | 0.65591294 |
104 | AURKA | 0.64549571 |
105 | MAP3K12 | 0.64021204 |
106 | BTK | 0.63966204 |
107 | SYK | 0.63079533 |
108 | STK24 | 0.62101068 |
109 | TXK | 0.61689483 |
110 | CDK6 | 0.61575197 |
111 | PAK1 | 0.61160050 |
112 | IKBKB | 0.60152057 |
113 | ALK | 0.59713653 |
114 | CDK8 | 0.58170877 |
115 | MAP3K5 | 0.57956013 |
116 | STK38L | 0.56762820 |
117 | NEK9 | 0.56752646 |
118 | FGFR1 | 0.55283567 |
119 | VRK1 | 0.54242922 |
120 | EEF2K | 0.53432351 |
121 | CDK2 | 0.53129875 |
122 | NTRK1 | 0.52281967 |
123 | SIK3 | 0.51532729 |
124 | ATM | 0.50891897 |
125 | LYN | 0.49830917 |
126 | BMX | 0.49557462 |
127 | ZAK | 0.49358202 |
128 | CSNK2A1 | 0.49080323 |
129 | TAOK2 | 0.48803160 |
130 | PRKD3 | 0.48688557 |
131 | CDK14 | 0.47099884 |
132 | CAMK1D | 0.46840130 |
133 | TEC | 0.46386930 |
134 | LCK | 0.45537426 |
135 | BRAF | 0.45286742 |
136 | CDK18 | 0.45197980 |
137 | PRKCI | 0.45006243 |
138 | CSNK2A2 | 0.44473858 |
139 | ARAF | 0.44384750 |
140 | CSK | 0.43530243 |
141 | IRAK2 | 0.42664444 |
142 | CDK15 | 0.40385553 |
143 | MOS | 0.39846101 |
144 | ROCK2 | 0.39266065 |
145 | AKT2 | 0.39054372 |
146 | CDK11A | 0.38397597 |
147 | CSNK1E | 0.37305079 |
148 | FGFR2 | 0.37171674 |
149 | PAK2 | 0.36855935 |
Rank | Gene Set | Z-score |
---|---|---|
1 | DNA replication_Homo sapiens_hsa03030 | 3.67903884 |
2 | Mismatch repair_Homo sapiens_hsa03430 | 3.20632582 |
3 | One carbon pool by folate_Homo sapiens_hsa00670 | 2.99552503 |
4 | Proteasome_Homo sapiens_hsa03050 | 2.84514338 |
5 | RNA polymerase_Homo sapiens_hsa03020 | 2.69698116 |
6 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 2.63207642 |
7 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 2.26643966 |
8 | RNA transport_Homo sapiens_hsa03013 | 2.19414348 |
9 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.15589482 |
10 | Other glycan degradation_Homo sapiens_hsa00511 | 2.14923893 |
11 | Protein export_Homo sapiens_hsa03060 | 2.11844332 |
12 | Base excision repair_Homo sapiens_hsa03410 | 2.10517233 |
13 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 2.06174797 |
14 | Nucleotide excision repair_Homo sapiens_hsa03420 | 2.02271252 |
15 | Homologous recombination_Homo sapiens_hsa03440 | 1.99564343 |
16 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.95764156 |
17 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.88193152 |
18 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.86845067 |
19 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.85850247 |
20 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.85396695 |
21 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 1.78304746 |
22 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.75855546 |
23 | Cell cycle_Homo sapiens_hsa04110 | 1.75154075 |
24 | Lysosome_Homo sapiens_hsa04142 | 1.74322952 |
25 | Spliceosome_Homo sapiens_hsa03040 | 1.70800900 |
26 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.62737624 |
27 | * Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.60615812 |
28 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.51992816 |
29 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.48682705 |
30 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.48387918 |
31 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.45466838 |
32 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43864108 |
33 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.40552288 |
34 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 1.38717165 |
35 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.37417775 |
36 | Carbon metabolism_Homo sapiens_hsa01200 | 1.36072582 |
37 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.34647515 |
38 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.27053683 |
39 | Ribosome_Homo sapiens_hsa03010 | 1.26155712 |
40 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.25240579 |
41 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.24873563 |
42 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.24216143 |
43 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.22683593 |
44 | Legionellosis_Homo sapiens_hsa05134 | 1.20531993 |
45 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.20234300 |
46 | p53 signaling pathway_Homo sapiens_hsa04115 | 1.18430003 |
47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.17081719 |
48 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.15982700 |
49 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.15803413 |
50 | Huntingtons disease_Homo sapiens_hsa05016 | 1.14206682 |
51 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.12872418 |
52 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 1.12577624 |
53 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.10897051 |
54 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.09689467 |
55 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07351565 |
56 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.06734405 |
57 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 1.01613721 |
58 | Galactose metabolism_Homo sapiens_hsa00052 | 0.99118372 |
59 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.96706298 |
60 | RNA degradation_Homo sapiens_hsa03018 | 0.91427522 |
61 | Basal transcription factors_Homo sapiens_hsa03022 | 0.90889509 |
62 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.88344103 |
63 | Alzheimers disease_Homo sapiens_hsa05010 | 0.86643789 |
64 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.86195729 |
65 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.83161083 |
66 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.82960815 |
67 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.81823778 |
68 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.80663487 |
69 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.79670576 |
70 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.78656420 |
71 | Leishmaniasis_Homo sapiens_hsa05140 | 0.76733866 |
72 | Purine metabolism_Homo sapiens_hsa00230 | 0.76626539 |
73 | Apoptosis_Homo sapiens_hsa04210 | 0.76092675 |
74 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.75649716 |
75 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 0.70265578 |
76 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.69304371 |
77 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.69088817 |
78 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.68554636 |
79 | Measles_Homo sapiens_hsa05162 | 0.66968512 |
80 | Graft-versus-host disease_Homo sapiens_hsa05332 | 0.66115191 |
81 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.64012295 |
82 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.63023449 |
83 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.62842987 |
84 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.61656749 |
85 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.59759070 |
86 | Tuberculosis_Homo sapiens_hsa05152 | 0.58029087 |
87 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.57582837 |
88 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.57190570 |
89 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.56595227 |
90 | Phagosome_Homo sapiens_hsa04145 | 0.55584621 |
91 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.54209923 |
92 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.53426246 |
93 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.52280676 |
94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.51569479 |
95 | Allograft rejection_Homo sapiens_hsa05330 | 0.51051401 |
96 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.51011257 |
97 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.49516777 |
98 | Peroxisome_Homo sapiens_hsa04146 | 0.47793123 |
99 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.47103919 |
100 | Shigellosis_Homo sapiens_hsa05131 | 0.44802711 |
101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.44365969 |
102 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.44021419 |
103 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 0.43880292 |
104 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.43472343 |
105 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.41911352 |
106 | Influenza A_Homo sapiens_hsa05164 | 0.41492880 |
107 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.40786444 |
108 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.40731630 |
109 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.39489260 |
110 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.38893397 |
111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.38483917 |
112 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.38469674 |
113 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.38377016 |
114 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.38163459 |
115 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.37573169 |
116 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 0.37394903 |
117 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.36200705 |
118 | * Metabolic pathways_Homo sapiens_hsa01100 | 0.36189539 |
119 | Adherens junction_Homo sapiens_hsa04520 | 0.35459144 |
120 | Lysine degradation_Homo sapiens_hsa00310 | 0.35254244 |
121 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.35019457 |
122 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.32008590 |
123 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31874698 |
124 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.31273227 |
125 | Osteoclast differentiation_Homo sapiens_hsa04380 | 0.31060917 |
126 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.30738713 |
127 | Mineral absorption_Homo sapiens_hsa04978 | 0.30511399 |
128 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.26645157 |
129 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 0.26444371 |
130 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.25205212 |
131 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.24990090 |
132 | Pertussis_Homo sapiens_hsa05133 | 0.24332418 |
133 | Thyroid cancer_Homo sapiens_hsa05216 | 0.21829116 |
134 | Tight junction_Homo sapiens_hsa04530 | 0.19669178 |